zoledronic acid has been researched along with Cell Transformation, Neoplastic in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 3 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Coleman, RE; Young, RJ | 1 |
| Gould, MN; Gumperz, JE; Haag, JD; Mirrielees, JA; Sharma, D; Wilke, LG; Zumwalde, NA | 1 |
| Albert, JD; Chalès, G; Duval, H; El Mansouri, L; Guggenbuhl, P; Hajjaj-Hassouni, N; Meadeb, JM | 1 |
| Boccadoro, M; Bosia, A; Cavallo, F; Coscia, M; Curcio, C; Forni, G; Holen, I; Iezzi, M; Massaia, M; Mönkkönen, H; Musiani, P; Pantaleoni, F; Quaglino, E; Riganti, C | 1 |
4 other study(ies) available for zoledronic acid and Cell Transformation, Neoplastic
| Article | Year |
|---|---|
Zoledronic acid to prevent and treat cancer metastasis: new prospects for an old drug.
Topics: Antineoplastic Agents; Bone Neoplasms; Cell Transformation, Neoplastic; Clinical Trials, Phase III as Topic; Diphosphonates; Humans; Imidazoles; Metabolic Networks and Pathways; Neoplasm Metastasis; Neoplasms; Zoledronic Acid | 2013 |
Analysis of Immune Cells from Human Mammary Ductal Epithelial Organoids Reveals Vδ2+ T Cells That Efficiently Target Breast Carcinoma Cells in the Presence of Bisphosphonate.
Topics: Carcinoma, Intraductal, Noninfiltrating; Cell Line, Tumor; Cell Transformation, Neoplastic; Diphosphonates; Female; Humans; Imidazoles; Immunologic Surveillance; Interferon-gamma; Mammary Glands, Human; Organoids; Primary Cell Culture; T-Lymphocytes; Zoledronic Acid | 2016 |
Bifocal sarcomatous transformation of Paget's disease: a case report.
Topics: Aged, 80 and over; Bone Density Conservation Agents; Bone Neoplasms; Calcium; Cell Transformation, Neoplastic; Diphosphonates; Humans; Imidazoles; Male; Osteitis Deformans; Osteosarcoma; Pleural Effusion; Tomography, X-Ray Computed; Vitamin D; Zoledronic Acid | 2009 |
Zoledronic acid repolarizes tumour-associated macrophages and inhibits mammary carcinogenesis by targeting the mevalonate pathway.
Topics: Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Diphosphonates; Female; Genes, erbB-2; Imidazoles; Interferon-gamma; Interleukin-10; Macrophages; Mammary Glands, Animal; Mammary Neoplasms, Animal; Metabolic Networks and Pathways; Mevalonic Acid; Mice; Mice, Inbred BALB C; Mice, Transgenic; Neovascularization, Pathologic; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Protein Prenylation; Vascular Endothelial Growth Factor A; Zoledronic Acid | 2010 |